1008526-71-3

Usage

Uses

Used in Organic Synthesis:
1-Boc-3-hydroxy-3-(aminomethyl)azetidine is used as a building block for the synthesis of complex organic molecules, leveraging its Boc-protected amine and hydroxyl functionalities for stable and versatile reactions.
Used in Medicinal Chemistry:
In the pharmaceutical industry, 1-Boc-3-hydroxy-3-(aminomethyl)azetidine is used as a key intermediate in the development of new drugs, due to its ability to be incorporated into various medicinal compounds and its potential to enhance the properties of existing pharmaceuticals.
Used in Materials Science:
1-Boc-3-hydroxy-3-(aminomethyl)azetidine is utilized as a component in the creation of advanced materials, such as polymers and petrochemicals, where its unique structural features contribute to the desired material properties.
Used in Chemical Research and Development:
1-Boc-3-hydroxy-3-(aminomethyl)azetidine is employed as a research tool for exploring new chemical reactions and mechanisms, particularly those involving the Boc-protected amine and hydroxyl group, to expand the scope of synthetic chemistry and discover novel applications.

Upstream product

• 1008526-70-2 3-hydroxy-3-(nitromethyl)azetidin-1-carboxylic acid tert-butyl ester 
• 398489-26-4 tert-butyl 3-oxoazetidine-1-carboxylate 

Downstream Products

• 1799438-98-4 6-oxo-5-oxa-2,7-diazaspiro[3.4]octane-2-carboxylic acid tert-butyl ester 
• 1363381-20-7 tert-butyl 7-oxo-5-oxa-2,8-diazaspiro[3.5]nonane-2-carboxylate 
• 1251011-05-8 tert-butyl 5-oxa-2,8-diazaspiro[3.5]nonane-2-carboxylate 

Relevant academic research and scientific papers

PYRAZINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS

Pyridine carbamates, pharmaceutical compositions containing pyridine carbamates, and uses of the pyridine carbamates and pharmaceutical compositions for modulating GluN2B receptors and for treating diseases, disorders, and medical conditions mediated by GluN2B receptor activity.

PYRAZINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS

Pyridine carbamates, pharmaceutical compositions containing pyridine carbamates, and uses of the pyridine carbamates and pharmaceutical compositions for modulating GluN2B receptors and for treating diseases, disorders, and medical conditions mediated by GluN2B receptor activity.

QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS

The present application relates to novel quinazoline compounds as inhibitors of type I receptor tyrosine kinases, the pharmaceutical compositions comprising one or more of the compounds and salts thereof as an active ingredient, and the use of the compounds and salts thereof in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals and especially in humans.

QUINAZOLINE COMPOUND FOR EGFR INHIBITION

Disclosed is a novel quinazoline compound. Specifically, disclosed are a compound represented by the formula (I) and a pharmacologically acceptable salt.

THIENO-PYRIDINE DERIVATIVES AS MEK INHIBITORS

A series of thieno[2,3-b]pyridine derivatives which are substituted in the 2- position by a substituted anilino moiety, being selective inhibitors of human MEK (MAPKK) enzymes, are accordingly of benefit in medicine, for example in the treatment, of inflammatory, autoimmune, cardiovascular, proliferative (including oncological) and nociceptive conditions.

FUSED THIOPHENE DERIVATIVES AS MEK INHIBITORS

A series of 4,5,6,7-tetrahydrothieno[2,3-c]azepin-8-one derivatives, and analogues thereof, which are substituted in the 2-position by a substituted anilino moiety, being selective inhibitors of human MEK (MAPKK) enzymes, are accordingly of benefit in med